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Abstract
Objective Common surgical treatments for trigeminal neuralgia (TN) includemicrovascular decompression (MVD) and percutaneous
procedures (glycerol rhizolysis; thermocoagulation; and balloon compression). Although the efficacy of each procedure has been
documented, direct comparisons of their relative efficacies for TN are lacking.We aimed to directly compare long-term outcomes after
first-time MVD with percutaneous surgery in primary (idiopathic and classical) TN and identify predictors of outcome.
Methods We conducted a retrospective analysis of prospectively collected data on 185 patients undergoing MVD and 129
undergoing percutaneous surgery. Procedures were performed by one of two neurosurgeons in a single centre; an independent
observer collected long-term follow-up data by interviews, using the same outcome measures for all procedures.
Results MVD patients were younger than those undergoing percutaneous surgery (P <.001). MVD provided superior initial pain
relief (P <.001): 87.0% had Barrow Neurological Institute class I or II pain scores after MVD compared with 67.2% after
percutaneous surgery. The complication rate for percutaneous procedures was 35.7% and for MVDs was 24.9% (P =.04),
including minor and transient complications. Kaplan-Meier analysis demonstrated that MVD provided longer pain relief than
percutaneous procedures (P <.001); 25% of patients had recurrence at 96months followingMVD compared with 12months after
percutaneous surgery. Subgroup analysis showed that balloon compression provided more durable relief amongst percutaneous
procedures. Multivariate analysis revealed that post-operative numbness and age were prognostic factors for percutaneous
procedures (P =.03 and .01, respectively).
Conclusions MVD provides better initial pain relief and longer durability of relief than percutaneous surgery, although carrying a
small risk of major complications. Amongst percutaneous procedures, balloon compression gave the most durable relief from
pain. Older age and post-operative numbness were predictors of good outcome from percutaneous surgery. These results can help
clinicians to counsel patients with primary TN on neurosurgical treatment selection for pain relief.
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Introduction
Trigeminal neuralgia (TN) is a syndrome of paroxysmal, se-
vere facial pain in the trigeminal nerve sensory distribution.
The more definitive treatment for TN is microvascular decom-
pression (MVD) to relieve the causative physical compression
of the trigeminal nerve by a neighbouring blood vessel [12,
11]. Other surgical treatments are ablative, aiming to injure the
nerve to improve pain, and include three percutaneous proce-
dures (glycerol rhizolysis, GR; thermocoagulation, TC; bal-
loon compression, BC) and stereotactic radiosurgery (SRS).
The long-term relief rates forMVDhave been reported to range
between 70 and 80% at 5–10 years in several large series [4, 42,
52]. The relief rates for percutaneous surgery for TN are more
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variable and influenced by surgical technique and patient factors
[6, 20, 28, 44, 46, 34, 35]. Comparing between studies is often
challenging owing to the heterogeneity in outcome measures
employed. According to a recent classification, there are three
diagnostic categories of TN: ‘idiopathic TN’ is primary TN with-
out any identifiable causes after appropriate investigations [9],
‘classical TN’ is primary TN with neurovascular compression of
the trigeminal nerve root demonstrated on imaging, and ‘second-
ary TN’ is TN due to an underlying confirmed neurological dis-
ease. Although many studies report outcomes for individual types
of procedure, few studies have directly compared MVDwith per-
cutaneous procedures in terms of long-term outcomes while con-
trolling for potentially confounding patient factors [48, 49] such as
atypical TN, recurrent pain or repeat surgery, andmultiple sclerosis
(MS). Therefore, a direct comparison of MVD versus percutane-
ous procedures with long-term outcomes, in the context of first-
time surgery for patients with primary (classical or idiopathic) TN,
would be important in guiding clinicians on neurosurgical
decision-making and counselling TN patients on surgical options.
Here, we performed a retrospective analysis of prospective-
ly collected data from a large patient cohort, comparing long-
term outcomes of MVD with percutaneous procedures (GR,
TC, and BC) in a relatively homogenous population of prima-
ry (idiopathic and classical), typical TN patients undergoing
first-time surgery. All procedures were performed by only two
experienced neurosurgeons in a single centre, and an indepen-
dent observer collected long-term follow-up data with the
same outcome measures to minimise biases.
Methods
Patient characteristics
This study had patient consent and institutional ethical
board approval. Clinical data for all consecutive patients
who underwent surgery for TN in University Hospital
Southampton were prospectively collected. Between 1996
and 2012, 622 surgical procedures were performed for TN;
185 patients who had MVD and 129 who had percutaneous
surgery (54 GR, 49 TC, and 26 BC) were included in this
study (Fig. 1 and Table 1). Inclusion criteria were idiopathic
or classical TN without MS or tumours (appropriate inves-
tigations including MRI were performed in all patients to
exclude these) [9], type 1 TN, first-time surgery for TN, and
more than 12-month follow-up. Ten patients who had an
MVD were lost to follow-up; 1 patient with a percutaneous
procedure (TC) was lost to follow-up (P = 0.055, 2-sided
Fisher’s exact test). Cases with MS or repeat surgery have
been reported separately [34, 35]. All patients in this work
had typical (Burchiel type I [8]) TN pain, meeting the
criteria of pain in the distribution of the trigeminal nerve
(Vn); an intermittent, paroxysmal course; shock-like lanci-
nating character; light-touch triggers; and initial response to
TN medications. There were no exclusions from surgical
treatment on purely age or comorbidity grounds. A pooled
cohort analysis of all percutaneous TN procedures in our
centre has been previously published [34].
Fig. 1 Flow chart showing the
number of patients included in
this study. ‘TN1’, classical or
idiopathic, type 1 trigeminal
neuralgia; ‘TN2’, atypical, type 2
trigeminal neuralgia
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Data collection and patient follow-up
MVD, GR, and TC have been employed in our centre for over
20 years, whereas BC was introduced in 2010 after the ap-
pointment of a second neurosurgical pain consultant (GV).
Patient data were collected from operation notes and clinic
letters. Routine clinic follow-up of these patients was conduct-
ed at 3 months and 18months after their operation. Additional
telephonic follow-up was conducted and/or questionnaires
were completed to obtain long-term data. An independent,
unbiased research doctor (I.N.) or specialist TN nurse (A.L.)
performed these long-term interviews, minimising potential
reporting biases from patients being reluctant to disappoint
their treating clinician by directly reporting poorer outcomes
to them. Follow-up time extended up to 20 years (minimum 1
year; mean 51.8 months).
Initial pain relief (3 months post-procedure) was defined
according to the Barrow Neurological Institute (BNI) pain
intensity score [41]: ‘class I, no pain and no analgesic treat-
ment needed; class II, occasional TN pain not requiring med-
ication; class III, some TN pain that is adequately controlled
on medication; class IV, some TN pain, not adequately con-
trolled on medication; and class V, severe TN pain, with
minimal/no relief from the procedure’. Time to recurrence
after a procedure was defined as time between the operation
and restarting of severe TN pain not adequately controlled by
medication and/or needing re-operation. New facial numbness
post-procedure was classified as none/mild, moderate, and
dense, with an additional category of ‘bothersome’ numbness
that was counted as a complication due to its intrusive nature.
Sensory disturbance was assessed by physical examination at
outpatient visits and patients’ own reports at telephone inter-
view on how they themselves assessed the numbness.
The reporting period began before the availability of
cisternography using fine-cut MRI with gradient echo
sequences (3D constructive interference in steady state,
CISS), which became available in our centre from the year
2000; prior to this, lower resolution MRI images with MR
angiography alone were used from a 0.5-T scanner. Pre-
operatively all MR films were assessed for neurovascular
compression (NVC) by the consultant neurosurgeon and a
consultant neuroradiologist.
Selection of procedure
All operations were performed by 1 of 2 consultant neurosur-
geons (G.V. and O.S.) directly or under their personal super-
vision. Both surgeons were fully trained and well-experienced
in all procedures prior to operating on cases for this study. The
decision-making strategy we used for selecting operations for
individual patients is in line with published algorithms [1, 45].
MVDwas offered to all patients with TN who were medically
fit and relatively young, and where the MRI scan suggested
NVC. All these patients were additionally counselled for a
partial sensory rhizotomy (PSR), as a ‘fall-back’ position if
no convincing NVC was found at operation. When NVC was
observed intra-operatively, an MVD was completed; other-
wise the operation would be converted to a PSR; this occurred
in only 3 cases. Where the MRI did not suggest NVC, patients
were offered the option of a percutaneous lesion or (if medi-
cally fit and young) exploration with MVD or probable PSR.
For patients who were less medically fit, older, and/or unwill-
ing to undergo a larger, longer operation, a percutaneous pro-
cedure was offered. Given this, the majority of patients under-
going MVD had classical TN (with NVC demonstrated on
imaging), whereas those undergoing percutaneous surgery
were a more mixed population of idiopathic TN and classical
TN. Patients with significant V1 pain were not offered TC due
to a risk of corneal anaesthesia. All patients were counselled
on all procedures, with the final choice of procedure largely








Variable MVD Percutaneous surgery GR TC BC
Procedures, n 185 129 54 49 26
Male procedures, n 88 50 24 19 7
Female procedures, n 97 79 30 30 19
Age (mean), year 58.5 72.7 70.9 74 73
Age range, year 24.3–83.0 43.5–93.7 46.8–88.7 44.0–92.0 51.0–94.0
Side (L:R) 0.43:0.57 0.43:0.57 0.50:0.50 0.41:0.59 0.35:0.65
V1 only, % 7.3 2.5 5.9 0 0
V2 only, % 21.3 16.4 5.9 25 21.7
V3 only, % 17.7 18 9.8 25 21.7
V1 and V2, % 18.9 19.7 31.4 4.2 26.1
V2 and V3, % 20.1 31.1 27.5 41.7 17.4
V1–3, % 14.6 12.3 19.6 4.2 13
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dependent on individual patient preference. All patients were
interviewed face-to-face in an outpatient setting by the con-
sultant surgeon to confirm diagnosis and discuss treatment
options. Information leaflets were available, as was telephonic
contact with a specialist nurse who was generally present dur-
ing the initial consultation.
The vast majority of patients offered MVD accepted it. A
few were unsuitable due to comorbidity, and most without
NVC (mainly early in the series, before the quality of MR
had been improved) offered an exploration similarly agreed,
expecting a partial sensory rhizotomy if exploration was neg-
ative. Patients over 85 years old were excluded for MVD as
none was medically suitable. All cases up to 75 years were
offered open surgery when fit, as were those up to 80 in rea-
sonable health, and only the exceptionally fit cases aged over
80 years were offered open surgery. Many of the elderly pa-
tients however preferred a shorter ‘day-case’ percutaneous
procedure, declining open surgery. Records of exact numbers
of patients who were offered surgery but declined were not
available; however, the senior author is confident of small
numbers for those with probable NVC and medically fit
who declined MVD, and for those without NVC and offered
exploration, who declined this option. Similarly, we do not
have records for the exact number of patients with probable
NVC who were not offered MVD due to age/medical
comorbidities.
Although SRS was not available at our centre, patients
were referred for SRS to another centre where mass lesions
of Meckel’s cave/cavernous sinus could be simultaneously
treated by this modality (two patients), or critical
anticoagulation ruled out a percutaneous procedure requiring
even only temporary reversal (one patient). In these cases,
there was no need for immediate pain relief. However, due
to limited facilities for SRS in the UK during this study period
and geographical distance of these from our centre, SRS was
not offered as a ‘surgical’ first-line in primary TN.
Operative technique
Percutaneous procedures were performed under general an-
aesthesia or sedation with fluoroscopic guidance, with mini-
mal variation in technique between cases. For GR, a 20-gauge
needle was inserted into the medial foramen ovale following
Härtel’s technique, and advanced deep toward the clivus on a
lateral projection. After reversal of anaesthesia, contrast was
injected with the patient in the sitting position and head flexed
forwards; contrast was slowly replaced with glycerol (0.36 ml,
the median volume of Meckel’s cave). The needle was then
withdrawn, with patient position maintained for at least 2 h.
For TC, a similar needle insertion technique was used, with
the needle tip placed more laterally in the foramen ovale to
reach the trigeminal ganglion. Electrode tip position was con-
firmed by awake testing before re-sedation and heating the
electrode to between 65 and 70°C for 60 s. One thermal lesion
was made, except where there was combined V2 and V3
neuralgia with evoked paraesthesiae in only one of these di-
visions, in which case a second lesion was performed for the
other division following needle adjustment and re-testing.
Following the same needle insertion technique via the mid-
dle of the foramen ovale on its posterior rim, with a soft
Fogarty balloon and minor test inflation with contrast to con-
firm correct balloon configuration, Vn compression entailed
balloon inflation with 0.35–0.50 ml of contrast to obtain a
‘pear’ shape (known to improve pain outcomes [33]), with
three alternating cycles of 60s of inflation and 60s of deflation.
For MVD, the operative technique was similar to that of
published techniques [5, 18, 31]. Following a small
retrosigmoid craniotomy, Vn was inspected under the micro-
scope for vascular compression anywhere along its course.
Arteries causing compression were dissected from the trigem-
inal root and then padded with shredded Teflon felt, or the
vessels were elevated in a Teflon sling sutured to the
tentorium. Patency of the superior cerebellar artery past the
sling was confirmed using either micro-Doppler or, more re-
cently, intra-operative indocyanine green angiography.
Compressive veins were coagulated and divided. No adverse
events followed vein coagulation. The veins divided were
usually transverse, draining to the superior petrosal vein, or
in one or two, the superior petrosal vein itself. Neurovascular
compression of Vn was noted intra-operatively using a pub-
lished grading system [27]: grade I, mere contact with Vn;
grade II, displacement or distortion of the nerve root; and
grade III, marked indentation of Vn.
Statistical analysis
Statistical analysis was performed using IBM SPSS 25 (IBM
Analytics, New York) software, with a significance level of P
< .05 for all tests. The 2-sided chi-square test or Fisher’s exact
test was used to compare proportions between groups of pa-
tients. Kaplan-Meier curves were compared by the log-rank
test. Data were censored if there was no pain recurrence at the
most recent follow-up. To identify predictors of pain relief,
univariate analysis was performed by logistic regression; mul-
tivariate logistic regression was performed using those vari-
ables exhibiting a P < .2 from univariate analysis.
Results
Patients undergoing MVD were significantly younger than
those undergoing a percutaneous procedure (mean age 58.5
years vs 72.7 years, respectively; P < .001, unpaired two-
tailed t-test; range 24.3–83.0 years for MVD and 43.5–93.7
years for percutaneous procedures) and had a shorter duration
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of pre-operative TN pain (mean 7.05 years compared with
9.14 years, respectively; P = .022, two-tailed t-test).
Initial relief
For MVD, 87.0% of operations yielded class I or II pain relief
at 3 months, in comparison with 67.2% of patients who had a
percutaneous procedure. Only 7.0% of patients who had un-
dergone MVD and 11.7% of patients who had undergone a
percutaneous procedure had little or no relief after their oper-
ation (BNI class IV and V). Comparing the distributions of
initial pain relief demonstrated that MVDs provided signifi-
cantly better initial relief compared with percutaneous proce-
dures (2-sided chi-square test, P < .001; Fig. 2a).
Subgroup analysis showed that initial class I or II relief
rates for GR, TC, and BC were 63.0%, 62.5%, and 84.6%,
respectively. Little or no pain relief (class IV or V) was
achieved after 16.7%, 10.4%, and 3.8% of GR, TC, and BC
procedures, respectively. MVD provided significantly better
initial relief than GR and TC (P < .001 for both MVD vs GR
and MVD vs TC, chi-square test) but not compared with BC
when comparing the distributions of pain relief (P = .45, chi-
square test). There were no significant differences in distribu-
tions of initial pain relief scores between GR, TC, and BC (GR
vs TC, P = .68; GR vs BC, P = .21; TC vs BC, P = .20, chi-
square test; Fig. 2b).
Complications
Following MVD, there were 3 (1.6%) cases of CSF leak re-
quiring temporary CSF diversion with a lumbar drain, 8
(4.3%) cases of minor stroke (typically some hemisensory loss
andmild weakness that improved), 2 (1.1%) cases of chemical
meningitis that recovered, and 1 (0.5%) case of deep venous
thrombosis (DVT). Two (1.1%) patients reported facial
paraesthesiae and 7 (3.8%) reported dysaesthesiae. There
was one (0.5%) death after an MVD due to a post-operative
posterior fossa haematoma in a patient with underlying but
peri-operatively treated coagulopathy. The commonest com-
plications were minor: ataxia (9.7%) and diplopia (5.9%)
which improved (Fig. 3a).
After a percutaneous procedure, there were 15 (11.6%)
cases of minor dysaesthesiae and 3 (2.3%) of major
dysaesthesiae, 3 (2.3%) of bothersome numbness, 12 (9.3%)
I o

































Fig. 2 Initial pain relief outcomes, reported using the Barrow
Neurological Institute (BNI) pain scale, at 3 months. a A plot of BNI
pain scores after MVD and percutaneous surgery; ‘*’ denotes significant-
ly better BNI scores after MVD compared with percutaneous procedures
(P < .001). b A plot of outcome scores after percutaneous surgery classi-
fied according to procedure type. ‘GR’, glycerol rhizolysis; ‘TC’,






























































































































































Fig. 3 Plots of complication rates after MVD (a) and percutaneous surgery (b). For b, motor weakness and VIn palsy after percutaneous surgery were
transient
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of reduced corneal reflex, and 9 (7.0%) of facial paraesthesiae
(Fig. 3b). There were no deaths or cases of anaesthesia
dolorosa. Complications stratified by type of percutaneous
procedure are indicated in Supplementary Table 1. The overall
complication rate (including minor and transient complica-
tions) for MVD was 24.9% and for percutaneous procedures
was 35.7% (P = .04, Fisher’s exact test).
Numbness
At 3-month follow-up following MVD, 4.3% of patients had
mild to moderate facial numbness, and 1.6% had dense numb-
ness; there were no cases of bothersome numbness. In con-
trast, 90.4% of percutaneous cases developed mild to moder-
ate numbness, and there were significantly more cases of
dense (6.1%) and bothersome (2.6%) numbness than with
MVD (P = .006, Fisher’s exact test; Fig. 4a).
Subgroup analysis of percutaneous procedures showed that
BC generated a greater proportion of cases with dense or
bothersome post-operative numbness than GR and TC
(23.1% in BC, 5.0% in GR, and 4.2% in TC; BC vs GR, P
= .05; BC vs TC, P = .02, Fisher’s exact test; Fig. 4b). There
was no significant difference in the proportion of cases with
dense/bothersome numbness with GR compared with TC (P =
1.00, Fisher’s exact test).
Durability of pain relief
Kaplan-Meier (KM) analysis for time to recurrence of TN
demonstrated that MVD provided significantly longer pain
relief compared with percutaneous procedures overall (P <
.001, log-rank test; Fig. 5a). The median time to pain recur-
rence for percutaneous procedures was 36 months (95% con-
fidence interval, CI, 24.9–47.1 months) and was not yet
reached for MVDs; 25% of patients had pain recurrence at
96 months following anMVD compared with only 12 months
after a percutaneous procedure.
Subgroup analysis confirmed that the durability of pain relief
forMVDwas significantly better compared with GR and TC (P
< .001 for both MVD vs GR and MVD vs TC, log-rank test),
and non-inferior to BC (P = .27, log-rank test). Themedian time
to pain recurrence was 29 months (95% CI 16.1–41.9 months)
for GR, 30 months (95% CI 8.6–51.4 months) for TC, and not
yet reached for BC. Twenty-five percent of patients had pain
recurrence at 5 months following a GR, 12 months after a TC,
and 26 months after a BC. Although there was no difference in
durability of relief after a GR compared with TC (P = .24, log-
rank test), BC provided significantly longer pain relief com-
pared with GR and TC (P = .011 for BC vs GR; P = .031 for
BC vs TC, log-rank test; Fig. 5b).
Predictors of pain relief
For MVD, age, sex, pre-operative duration of TN pain, and
trigeminal division of pain were not significant predictors of
favourable outcome after surgery (as defined by initial post-
operative BNI score I or II and no recurrence on long-term
follow-up) using univariate analysis. With pre-operative MRI
findings of neurovascular contact or compression of Vn, there
was a favourable outcome in more cases (P = .10, OR 2.48,
95% CI 0.83–7.42), and similarly for severe intra-operative
NVC (grade II or III; P = .06, OR 2.12, 95% CI 0.97–4.65) on
univariate analysis (Table 2); these differences were not sta-
tistically significant. The type of compressive blood vessel
(artery or vein) was not associated with outcome.
Multivariate logistic regression analysis revealed no signifi-
cant predictors of outcome after MVD. The causative vessel































































Fig. 4 Post-operative numbness. a A plot showing the degree of post-
operative numbness after MVD and percutaneous surgery. ‘*’ denotes a
significantly higher degree of dense or bothersome numbness after per-
cutaneous surgery than MVD (P = .006). b A plot of post-operative
numbness after percutaneous surgery, categorised according to procedure
type, showing a significantly higher degree of dense/bothersome numb-
ness after BC than GR or TC (P = .05 and .02, respectively)
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artery in 67.2%, anterior inferior cerebellar artery in 4.5%,
multiple arteries in 8.1%, an artery and a vein in 11.6%, and
a vein only in 8.6% of cases.
Univariate logistic regression confirmed that, for all percu-
taneous procedures combined, sex, side and distribution of TN
pain, and pre-operative duration of TN symptoms were not
predictors of outcome. Older age and the presence of post-
operative dense or bothersome numbness were the only sig-
nificant predictors of favourable outcome (P = .007, OR 1.06,
95% CI 1.02–1.10 for age; P = .02, OR 5.17, 95% CI 1.27–
21.12 for post-operative numbness). On multivariate logistic
regression analysis, both age and post-operative numbness
remained significant predictors of outcome (P = .01 and .03,
respectively; Table 3).
a b
Fig. 5 Long-term pain relief after first-time surgery for idiopathic TN. a
Kaplan-Meier curves of time to pain recurrence for MVD and all percu-
taneous procedures. ‘*’ denotes significantly better durability of relief
with MVD than percutaneous surgery (P < .001). ‘Perc’ denotes
percutaneous procedures. b Kaplan-Meier curves of GR, TC, and BC,
showing significantly higher durability of relief with BC than GR or TC
(*P = .011 and .031, respectively)
Table 2 Univariate and
multivariate logistic regression
analysis for predictors of outcome
for MVD. Note that ‘MRI NV
contact/distortion’, ‘mixed
arterial and venous compression’,
and ‘severe NVC’ are inter-
related (multi-collinear) variables,
and therefore only one of each
was included per model in the
multivariate analysis in conjunc-
tion with ‘right side’ [40].
Predictors giving a probability
value 0.05 < P < .10 are in italics
Variable Univariate analysis Multivariate analysis
95% CI 95% CI
Odds
ratio
Low High P Odds
ratio
Low High P
Age 0.995 0.966 1.02 .72
Male sex 1.587 0.779 3.233 .20
Right side 1.723 0.862 3.446 .12 1.603 0.794 3.233 .19
V1 pain 0.966 0.465 2.006 .93
V2 pain 0.659 0.276 1.577 .35
V3 pain 0.737 0.356 1.524 .41
Pre-operative TN duration
(years)
1.036 0.972 1.103 .27
MRI NV contact/distortion 2.481 0.829 7.429 .10 2.481 0.821 7.500 .11
Venous compression only 0.561 0.18 1.742 .32
Arterial compression only 1.22 0.552 2.694 .62
Mixed arterial and venous
compression
3.279 0.734 14.647 .12 3.253 0.724 14.607 .124
Post-operative numbness 0.77 0.195 3.044 .71
Severe NVC 2.121 0.967 4.65 .06 2.003 0.907 4.421 .086
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Discussion
Published outcomes of MVD and ablative treatments for TN
vary due to differences in surgical technique, outcome mea-
sures, patient selection, and study methods; most studies re-
port results for single techniques. In this large retrospective
analysis, we compare the long-term outcomes of MVD with
three types of percutaneous procedure in primary (classical or
idiopathic) TN, using the same outcome measures. Such re-
sults have rarely been reported together for direct comparisons
[19, 26, 13, 23, 15]. Key advantages of this study over prior
publications are the prospective data collection of a large
dataset, long-term follow-up by an independent observer (re-
ducing reporting bias), and performance of all procedures at a
single centre by only two neurosurgeons (mitigating surgical
heterogeneity). These advantages enhance the reliability of the
findings reported here. Our results indicate higher long-term
pain-free rates in patients treated with MVD compared with
percutaneous procedures, with balloon compression giving
better pain relief amongst percutaneous procedures.
The efficacy of MVD in our study, with 87% of patients
achieving initial BNI class I or II pain scores and 25% of
patients having pain recurrence by 96 months, is similar to
published observations [39, 38, 4, 43]. Wang et al. reported
a median time to recurrence of 94 months, with 25% of pa-
tients having a recurrence at 57 months [52]; Barker et al.
found that 70% of patients had class I relief 10 years after an
MVD [4], similar to Sarsam et al. (71%) [42]. In comparison,
67% of our patients had initial class I or II pain relief after a
percutaneous procedure, with the median time to recurrence of
36 months. Prior studies report excellent initial pain relief in
59–91% of patients after GR [51, 36], 80–100% after TC [47,
51], and 82–91% after BC [25, 2, 30]. These results are con-
sistent with our data in which GR and BC produced class I or
II pain scores in 63% and 85%, respectively; the lower TC
initial pain-free rate (63%) reported here compared with other
studies may reflect the cautious technique (with a single ther-
mal lesion) we employed, knowing that the lesion could be
repeated in the event of recurrence.
Previous work has suggested a correlation between sensory
loss and pain relief following destructive procedures for TN
[11, 7], which would be explained by more destructive lesions
giving more durable relief. In line with this, we found that
post-operative numbness is a significant predictor of
favourable outcome for percutaneous procedures but not for
MVD and is also a significant predictor for lack of recurrence
in long-term follow-up. Moreover, BC produced a higher lev-
el of post-operative numbness, and this coincided with greater
durability of relief compared with GR and TC. There was also
a higher complication rate with BC compared with the other
techniques and previous reports, although most of these com-
plications were minor sensory disturbances such as
paraesthesiae and minor dysaesthesiae. In our experience,
most patients are willing to accept a degree of numbness
and/or sensory disturbance post-operatively if they achieve
adequate pain relief from TN. The technique we employed,
with three cycles of 60 s of balloon compression, is likely to
have a stronger destructive effect than a single cycle of com-
pression reported in some studies [24, 3], thus explaining
these results. To our knowledge, age has not been reported
as a predictor of outcome from percutaneous surgery in other
series. Age had a weak effect according to our data. It remains
to be confirmed in other large series whether advancing age
provides a ‘true’ benefit for efficacy of these procedures, or
whether this is due to older patients possibly being more sto-
ical and less likely to request further surgery.
Previously reported prognostic factors for MVD include
male sex, arterial compression, duration of TN pain, and typ-
ical TN [14, 16, 32, 50]. Our analysis demonstrated more
patients with neurovascular contact/compression seen on
Table 3 Univariate and
multivariate logistic regression
analysis for predictors of outcome
(as defined by initial post-
operative BNI score I or II and no
recurrence on long-term follow-
up) for percutaneous surgery.
Significant predictors are in bold
(P < .05)
Variable Univariate analysis Multivariate analysis
95% CI 95% CI
Odds
ratio
Low High P Odds
ratio
Low High P
Older age 1.056 1.015 1.098 .007 1.055 1.014 1.098 .008
Male sex 0.739 0.346 1.577 .43
Right side 1.347 0.641 2.827 .43
V1 pain 1.634 0.763 3.499 .21
V2 pain 1.5 0.603 3.732 .38
V3 pain 0.641 0.306 1.342 .24
Pre-operative TN duration (years) 0.995 0.951 1.041 .83
Dense/bothersome post-operative
numbness
5.171 1.266 21.12 .022 5.106 1.187 21.972 .029
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MRI and severe NVC observed intra-operatively to had better
outcomes after MVD, although this difference was not statis-
tically significant. However, the reporting period of this study
started before the availability of high-resolution MRI with
gradient echo sequences, which has a higher sensitivity for
detecting NVC pre-operatively. Some previous studies have
proposed that the severity of NVC is important in determining
the success of MVD [17, 37], although others have not [52].
Other than physical compression, inflammation and demye-
lination have been proposed as pathophysiological causes of
TN [29, 10], explaining why decompressing Vn may not be
enough to resolve TN in certain cases [21].
MVD and percutaneous procedures have advantages and
limitations. While MVD provides superior long-term pain re-
lief overall, it is a larger and longer operation than percutane-
ous procedures, requires longer hospital stay, and carries a risk
(albeit low) of serious complications. Patients with ischaemic
stroke after MVD in this series had relatively mild neurolog-
ical deficits that improved. Theminor strokes were assumed to
be due to disruption or kinking of small brainstem perforators
during the mobilisation of the caudal loop of the superior
cerebellar artery from deep to the trigeminal nerve root.
Most minor strokes were revealed by direct enquiry of patients
during routine follow-up, by which time they had recovered
fully. In some early MVD cases, polyvinyl alcohol (Ivalon)
foam was used and resulted in two cases of chemical menin-
gitis, and thus we decided to use Teflon felt subsequently. In
the patient who unfortunately died after MVD due to a cere-
bellar haematoma, no vein was coagulated intra-operatively,
and their pre- and intra-operative correction of modest coag-
ulopathy associated with chronic myeloma was undertaken on
haematological advice.
Percutaneous procedures are less invasive, simpler to per-
form, need shorter hospital stay (typically not overnight), and
can also provide immediate relief. However, percutaneous
procedures generally provide shorter durability of relief com-
pared with MVD (although can be effectively repeated [34])
and have a higher risk of dysaesthesiae. Although the compli-
cation rate for percutaneous procedures was higher thanMVD
here, these complications were more minor. Similarly, a large
proportion of MVD complications were minor and transient,
including ataxia and diplopia. SRS is an alternative, minimally
invasive treatment for TN, which has a destructive effect on
Vn. It is used in cases where a longer latency between treat-
ment and pain relief is tolerated and/or for those unable to
undergo invasive surgery [22].
Limitations
Limitations of this study include the retrospective nature of the
analysis (although most surgical TN literature is retrospective)
[53]. Patients were not randomly assigned to a procedure, and
there was no blinding of procedure to clinicians or patients.
Indeed, there is a major need for more randomised controlled
trials in neurosurgical treatment of TN [53], though
randomisation poses its own challenges. There was a mixture
of patients with idiopathic and classical (primary) TN includ-
ed here, and further studies focusing on each category sepa-
rately would be beneficial. There were both longer follow-up
and more cases undergoing MVD, GR, and TC compared
with BC; with further follow-up of BC in the future, it will
be useful to determine likely differences between durability of
relief for MVD and BC in the longer term. Nevertheless, the
primary aim of this study was to compare MVD with all per-
cutaneous destructive procedures, as such studies are lacking.
There were differences in baseline characteristics (age and
duration of TN pain) betweenMVD and percutaneous surgery
cohorts, which may have possibly contributed to differences
in outcome, though older age in fact seemed to favour ablative
procedures. SRS was performed in only one idiopathic TN
case (and two cases with underlying tumours), so this selec-
tion bias was minimal. Our results apply only to primary (id-
iopathic and classical), type I TN, and not to atypical TN, MS,
or recurrent pain after previous surgery.
Conclusions
Surgical decision-making needs tailoring to the individual
patient and depends on many factors. Our large single-
centre analysis of first-time surgery for idiopathic and
classical (primary) TN shows that MVD provides superior
initial quality of relief and also durability of pain relief
than percutaneous surgery, although carrying a low risk of
major complications. Percutaneous procedures, particular-
ly BC with the reported parameters, provide good pain
relief with largely minor complications in patients less
suitable for or unwilling to have a major operation.
Older age and post-operative numbness are prognostic
factors for better outcome after percutaneous procedures.
We hope our data will aid surgeons in counselling TN
patients for selecting between these procedures, and we
propose these guidelines for first-time surgery in primary
TN (based on surgical parameters employed here):
1. For younger and medically fit patients, MVD should be
offered.
2. For older, less medically fit patients or those unwilling to
undergo an open operation, balloon compression is sug-
gested as first-line.
3. If balloon compression is not possible, glycerol rhizolysis
or thermocoagulation can be offered, although
thermocoagulation should be avoided in those with pure
V1 pain.
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The authors conducted a retrospective analysis of prospectively collected
data on 185 patients undergoingMVD, and 129 undergoing percutaneous
surgery for trigeminal neuralgia. MVD provided superior initial pain re-
lief. The complication rate for percutaneous procedures was 35.7% and
for MVDs was 24.9%. MVD provides better initial pain relief and longer
durability of relief than percutaneous surgery, although carries a small
risk of major complications. Amongst percutaneous procedures, balloon
compression gave the most durable relief from pain.
Although the main result of the study has been well known for years
that means MVD provides the best chance of a pain-free outcome, it is a
nice study comparing MVD with percutaneous techniques performed at
one institution. We have abandoned percutaneous techniques almost
completely because MVD can be safely performed also in elderly pa-
tients. Several studies have proven that. Our oldest patient was 87 years,
and we have several patients over the age of 80. Although MVD is an
‘open’ operation, it is a minimally invasive short surgery in the subarach-
noid space. That’s why we usually recommend MVD. If anaesthesia is
not indicated because of severe cardiopulmonary comorbidity, we usually
recommend radiation.
I would be reluctant to generally recommend coagulation of compres-
sive veins. If the veins are large and do not have collaterals, adverse
events after vein coagulation may occur.
After having said that, I congratulate the authors for a nice comparison
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